Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Synta's billion-dollar drug nears end of Phase III
Synta's billion-dollar drug nears end of Phase III
Synta's billion-dollar drug nears end of Phase III
Submitted by
admin
on February 2, 2009 - 10:43am
Source:
Fierce Biotech
News Tags:
Synta
drug trials
cancer
elesclomol
GSK
Headline:
Synta's billion-dollar drug nears end of Phase III
Do Not Allow Advertisers to Use My Personal information
